LONDON, May 18, 2023 /PRNewswire/ — Cystic fibrosis (CF), a challenging genetic disorder affecting the lungs and digestive system, has experienced remarkable advancements in therapeutics, instilling hope and enhancing the quality of life for those affected. This progressive disease involves the production of thick mucus, chronic lung infections, and compromised digestion. The realm of CF therapeutics … Read more
As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits RA’ANANA, Israel, May 18, 2023 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, announced today its financial results for the first quarter ended March … Read more
The publication in PLOS ONE shows that NAV-001 has robust single-dose efficacy against multiple mesothelin-expressing cancers and that tumor-produced Humoral Immunology-Oncology (HIO) factors negatively impact antibody drug internalization and efficacy. CHEYNEY, Pa., May 18, 2023 /PRNewswire/ — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announces today a publication describing … Read more
Amidst continued investment in growth, early education and care leader honored with prestigious franchise industry awards ATLANTA, May 18, 2023 /PRNewswire/ — Primrose Schools, the premier early education and care leader with more than 480 franchised locations, kicked off 2023 with the opening of eight new locations and an incoming pipeline totaling 17 schools currently … Read more
FLINT, Mich., May 18, 2023 /PRNewswire/ — Forum Health, LLC, the first nationwide network of integrative and functional medicine providers, has acquired Hormones by Design, one of the largest hormone replacement clinic networks in Texas. Hormones by Design is a renowned healthcare provider specializing in hormone replacement therapy with four Texas locations in Waco, San … Read more
eatCleaner® is the only patented and lab proven produce wash that removes up to 99.9% of unwanted residue including pesticides and has earned EPA’s Safer Choice label IRVINE, Calif., May 18, 2023 /PRNewswire/ — Grow Green Industries, Inc., the makers of eatCleaner® is proud to announce that our eatCleaner® Fruit and Veggie Wash products are … Read more
NEW YORK, May 18, 2023 /PRNewswire/ — According to the Skin Cancer Foundation, just five sunburns before the age of 20 can double your risk of developing melanoma. Children are at a higher risk for UV-induced sun damage and are even more susceptible to sunburns than adults due to their more thin, sensitive skin, and … Read more
NEW YORK, May 18, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed’s oral … Read more
WALTHAM, Mass., May 18, 2023 /PRNewswire/ — Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for both rare and prevalent devastating diseases, today announced the presentation of new preclinical data on novel AAV capsids for skeletal muscle, cardiac muscle, and central nervous system (CNS). This research will be presented in an oral session today at 1:30pm PT … Read more
SAN JOSE, Calif., May 18, 2023 /PRNewswire/ — BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high-value, traditionally undruggable targets, announced that Wolf Wiedemeyer, Ph.D., head of biology at BridGene, will be giving a presentation, titled “A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & … Read more